We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current OMER market cap is 579.5M. The company's latest EPS is USD -2.0330 and P/E is -4.92.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -48.15M | -39.77M | -39.03M | -59.16M | -35.41M |
| Net Income | -37.75M | -9.07M | -37.18M | -56.04M | -32.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 111.81M | 73.81M | 0 | 0 | 0 |
| Operating Income | -63.38M | -110.6M | -173.62M | -163.39M | -164.53M |
| Net Income | -84.49M | -138.06M | 194.24M | 47.42M | -117.81M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 493.07M | 378.27M | 437.49M | 356.31M | 313.34M |
| Total Liabilities | 507.02M | 403.25M | 508.82M | 480.91M | 467.51M |
| Total Equity | -13.95M | -24.98M | -71.33M | -124.6M | -154.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 136.97M | 181.04M | 419.27M | 590.97M | 378.27M |
| Total Liabilities | 245.99M | 301.79M | 395.49M | 505.29M | 403.25M |
| Total Equity | -109.02M | -120.75M | 23.78M | 85.68M | -24.98M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 109.55M | 74.73M | -41.78M | -87.77M | -119.82M |
| Investing | -88.79M | 27.45M | -61.93M | 11.23M | 47.26M |
| Financing | -1.13M | -106.08M | 98.43M | 71.56M | 66.98M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -60.07M | -100.09M | -109.72M | -86.48M | 74.73M |
| Investing | -3.4M | -67.03M | 193.71M | -127.56M | 27.45M |
| Financing | 60.7M | 174.53M | 6.32M | 124.25M | -106.08M |
| Market Cap | 579.5M |
| Price to Earnings Ratio | -4.92 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 81.57 |
| Price to Book Ratio | -23.2 |
| Dividend Yield | - |
| Shares Outstanding | 57.95M |
| Average Volume (1 week) | 2.4M |
| Average Volume (1 Month) | 1.1M |
| 52 Week Change | 174.73% |
| 52 Week High | 13.60 |
| 52 Week Low | 2.76 |
| Spread (Intraday) | 3.65 (28.08%) |
| Company Name | Omeros Corporation |
| Address |
3400 capitol blvd se tumwater, washington 98501 |
| Website | https://www.omeros.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
